Tuesday, March 28, 2017 9:36:42 AM
https://www.sec.gov/litigation/suspensions/2017/34-80318.pdf
Order:
https://www.sec.gov/litigation/suspensions/2017/34-80318-o.pdf
The Commission temporarily suspended trading in the securities of NewGen BioPharma because of questions regarding the accuracy and adequacy of publicly available information about the company, specifically (i) the identity of its former sole executive officer, director, and majority
shareholder; and (ii) possible undisclosed former and current controlling persons.
From the ORDER:
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of NewGen BioPharma Corp. (CIK No.0001537274) because of questions regarding the accuracy and adequacy of publicly available information, in periodic and other reports, about the company since at least January 9, 2014, specifically (i) the identity of its former sole executive officer, director, and majority shareholder; and (ii) possible undisclosed former and current controlling persons. NewGen BioPharma Corp. is a Nevada corporation whose current principal place of business is in Seattle,
Washington. Its stock is quoted on OTC Link LLC, operated by OTC Markets Group, Inc., under the ticker symbol NEWG.
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM